Scientists fight cancer with measles virus in groundbreaking trial
NCT ID NCT02364713
Summary
This study tested whether a specially engineered measles virus could be a better treatment than standard chemotherapy for women with advanced ovarian, fallopian, or peritoneal cancer that had stopped responding to platinum-based drugs. Participants were randomly assigned to receive either the experimental virus therapy or one of several standard chemotherapy drugs. The main goal was to see if the virus treatment helped patients live longer compared to chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN SEROMUCINOUS CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.